Literature DB >> 7508276

Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors.

R M Edwards1, W Trizna.   

Abstract

The inhibition of nitric oxide production has been shown to reduce RBF. The effects of the nitric oxide synthase inhibitors, N omega-nitro-L-arginine and NG-monomethyl-L-arginine, on afferent and efferent arterioles isolated from rabbit kidneys were examined. Under basal conditions, N omega-nitro-L-arginine (10(-7) to 10(-3) M) had no effect on efferent arteriole lumen diameter but caused a 40% decrease in the lumen diameter of afferent arterioles. In afferent and efferent arterioles precontracted with norepinephrine, N omega-nitro-L-arginine and NG-monomethyl-L-arginine (3 x 10(-4) M) markedly attenuated the vasorelaxant effects of the endothelium-dependent vasodilator acetylcholine. In both arterioles, the inhibitory effect of N omega-nitro-L-arginine on acetylcholine-induced relaxation could be reversed by L- but not D-arginine (10(-3) M). However, N omega-nitro-L-arginine had no effect on the relaxation produced by the endothelium-independent vasodilators prostaglandin E2 (afferent) and dopamine (efferent). These observations demonstrate that under the in vitro conditions used in this study, afferent arterioles but not efferent arterioles synthesize and release nitric oxide in the basal state. However, both arterioles release nitric oxide in response to an endothelium-dependent vasodilator. The results of this study provide further evidence for an important role of nitric oxide in the regulation of renal hemodynamics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508276     DOI: 10.1681/ASN.V451127

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

2.  Glucose dilates renal afferent arterioles via glucose transporter-1.

Authors:  Jie Zhang; Shan Jiang; Jin Wei; Kay-Pong Yip; Lei Wang; En Yin Lai; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

Review 3.  Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.

Authors:  Yang Yang; Gaosi Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

4.  Lack of contribution of nitric oxide synthase to cholinergic vasodilation in murine renal afferent arterioles.

Authors:  Sungmi Park; Benjamin J Bivona; Lisa M Harrison-Bernard
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-07

5.  Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.

Authors:  Tomoki Kosugi; Marcelo Heinig; Takahiro Nakayama; Thomas Connor; Yukio Yuzawa; Qiuhong Li; William W Hauswirth; Maria B Grant; Byron P Croker; Martha Campbell-Thompson; Li Zhang; Mark A Atkinson; Mark S Segal; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

6.  Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patients with type 2 diabetes.

Authors:  Markus P Schneider; Christian Ott; Stephanie Schmidt; Iris Kistner; Stefanie Friedrich; Roland E Schmieder
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.